Category Archives: Pharmaceuticals

Cephalon’s Billion Dollar Patent Struck Down

On April 8, 2013, the Federal Court upheld the trial court’s judgment of invalidity and unenforceability for Cephalon’s RE’516 patent.  Cephalon’s RE’516 patent used to protect their mainstay drug – Provigil®.  Provigil® is the brand name for modafinil which is used to treat sleep disorders.  In 2007, Cephalon, now owned by Teva Pharmaceuticals, had over $800 million in sales from Provigil®. Apotex, a generic drug manufacturer, challenged the validity and enforceability of Cephalon’s RE’516 patent, in Apotex, Inc. v. Cephalon Inc.  The trial court found…

Continue Reading....

Compounding Pharmacies – Good or Bad?

Compounding pharmacies are no longer serving their original purpose and can potentially be causing more harm than good.  Compounding pharmacies originally converted pills into a liquid form of medicine for individuals who could not swallow pills.  Now, some compounding pharmacies manufacturer prescription drugs in mass quantities and have been tied to outbreaks such as the fungal meningitis outbreak in 2012. There are thirty compounding pharmacies in eighteen states in the United States.  A House subcommittee is holding a hearing on April 16, 2013, to determine…

Continue Reading....

A Potential Godsend to Mothers-to-Be

After a 30-year hiatus, the Food and Drug Administration (FDA) has once again approved a drug to specifically treat morning sickness.  Diclegis, made by Canadian Duchesnay Inc., is scheduled to be available in June 2013.  Diclegis combines Vitamin B6 and antihistamine doxylamine in a time released formula to prevent nausea before it sets in. The same drug combination was marketed as Benedectin from the 1950’s to 1980’s.  Despite no conclusive medical evidence that it caused birth defects and court rulings in its favor, Merrell Dow…

Continue Reading....